We are dedicated to improving the lives of people with lymphedema, lipedema and chronic venous insufficiency through the use of our at-home treatments.
Employees: 11-50
Total raised: $10.4M
Investors 1
| Date | Name | Website |
| - | Galen Part... | galen.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 05.10.2012 | Series B | $10.4M | - |
Mentions in press and media 5
| Date | Title | Description |
| 05.10.2012 | Tactile Systems Technology Raises $10.4M in Series B Financing | Tactile Systems Technology Inc., a Minneapolis-based provider of at-home lymphedema treatment, has raised $10.4m in Series B financing. The round was led by Radius Ventures, with participation from Galen Partners. The company plans to use t... |
| 05.10.2012 | Tactile Systems Touches $10.4M Series B | MINNEAPOLIS, MN, Currently a leading provider of at-home lymphedema treatment, today announced it has secured $10.4 million of Series-B financing led by Radius Ventures. >> Click here for more funding data on Tactile Systems Touche... |
| 04.10.2012 | Company providing at-home lymphedema relief raises $10.4 million in Series B round | Location: Minneapolis, Minnesota Solution/Product: Flexitouch, the company’s sole product, is a pneumatic compression device that treats lymphedema, chronic edema, and non–healing venous ulcers. Money raised: $10.4 million in Series B; in 2... |
| 29.10.2007 | Life sciences briefing: Monday, Oct. 29, 2007 | Featured companies: Azaya Therapeutics, Global Care Solutions, Oxford Immunotec, RealSelf.com, Sequoia Pharmaceuticals, Tactile Systems Technology, WellGen, Zeltiq Aesthetics UPDATED: Expanded items on Oxford Immunotec, Zeltiq, Tactile Syst... |
| - | Company providing at-home lymphedema relief raises $10.4 million in Series B round | Tactile Systems Technology, a company that provides at home lymphedema treatment has raised $10.4 million in a Series B funding round, the company announced Thursday. Lynphedema is swelling that occurs, mainly in the arms, torso and legs du... |